Ma Jianfang, Li Chaoyang, Shao Chunkui, Gao Guoquan, Yang Xia
Department of Medicine, PLA 476th Hospital, Fuzhou, China.
Mol Vis. 2012;18:330-6. Epub 2012 Feb 4.
Plasminogen kringle 5 (K5) is a potent angiogenic inhibitor and specifically binds to the voltage-dependent anion channel believed to function as the K5 receptor (K5R). To investigate the role of K5R in diabetic retinopathy, the present study measured the expression levels of K5R in the retina of diabetic retinopathy models. In cultured retinal Müller cells, K5 inhibited vascular endothelial growth factor (VEGF) expression as shown with enzyme-linked immunosorbent assay and western blot analysis, suggesting that K5 has a direct effect on Müller cells.
To identify K5R in retinal Müller cells, ligand binding and competition assays as well as real-time reverse transcriptional polymerase chain reaction were performed in Müller cells. (125)I-K5 showed saturable binding to cultured Müller cells. The binding can be competed off by an excess amount of unlabeled K5 but not by angiostatin, demonstrating the specificity of the K5 binding to Müller cells. Consistent with the binding assay, reverse transcriptional polymerase chain reaction using voltage-dependent anion channel-specific primers detected the K5R mRNA in the Müller cells.
Interestingly, K5R mRNA expression in Müller cells was downregulated by diabetic conditions including hypoxia and high glucose medium. Incubation with K5 ligand prevented hypoxia-induced downregulation of K5R. Furthermore, K5R expression was also downregulated in the retina of the oxygen-induced retinopathy model, a model of ischemia-induced retinal neovascularization. In a type 1 diabetic rat model, K5R expression in the retina was significantly suppressed in rats that had diabetes for 5 and 8 weeks.
These results suggest that K5R is expressed in retinal Müller cells, which may mediate the inhibitory effect of K5 on VEGF expression. In diabetes conditions, K5R expression levels are decreased in the retina, which could contribute to the VEGF overexpression in diabetic retinopathy. These findings suggest that the decreased levels of K5R may also play a pathogenic role in diabetic retinopathy.
纤溶酶原kringle 5(K5)是一种有效的血管生成抑制剂,可特异性结合被认为作为K5受体(K5R)发挥作用的电压依赖性阴离子通道。为研究K5R在糖尿病视网膜病变中的作用,本研究检测了糖尿病视网膜病变模型视网膜中K5R的表达水平。在培养的视网膜Müller细胞中,K5抑制血管内皮生长因子(VEGF)表达,这通过酶联免疫吸附测定和蛋白质印迹分析得以证实,表明K5对Müller细胞有直接作用。
为在视网膜Müller细胞中鉴定K5R,在Müller细胞中进行了配体结合和竞争试验以及实时逆转录聚合酶链反应。¹²⁵I-K5显示与培养的Müller细胞有饱和结合。该结合可被过量未标记的K5竞争掉,但不能被血管抑素竞争掉,这证明了K5与Müller细胞结合的特异性。与结合试验一致,使用电压依赖性阴离子通道特异性引物的逆转录聚合酶链反应在Müller细胞中检测到了K5R mRNA。
有趣的是,包括缺氧和高糖培养基在内的糖尿病条件下调了Müller细胞中K5R mRNA的表达。用K5配体孵育可防止缺氧诱导的K5R下调。此外,在氧诱导性视网膜病变模型(一种缺血诱导的视网膜新生血管形成模型)的视网膜中,K5R表达也下调。在1型糖尿病大鼠模型中,糖尿病5周和8周的大鼠视网膜中K5R表达显著受到抑制。
这些结果表明K5R在视网膜Müller细胞中表达,这可能介导K5对VEGF表达的抑制作用。在糖尿病条件下,视网膜中K5R表达水平降低,这可能导致糖尿病视网膜病变中VEGF的过度表达。这些发现表明K5R水平降低也可能在糖尿病视网膜病变中起致病作用。